ERBB2 and breast carcinoma: In breast cancer molecular typing, luminal A and luminal B breast cancers have better prognosis than HER-2 positive and TNBC breast cancers, and the expression of PBK/TOPK in HER-2 positive and TNBC is higher than that in luminal A or luminal B types.